Driving Breakthroughs in Healthcare, One Bold Idea at a Time

All Articles

06 December 2024

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

Read More
02 December 2024

Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

Read More
04 November 2024

Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025

Read More
31 October 2024

Feldan Therapeutics announces the treatment of the first patient in the phase 1/2a clinical trial of its candidate fld-103, against Basal Cell Carcinoma

Read More
30 October 2024

Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development

Read More
20 September 2024

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed

Read More